IGF2BP1 is found to be a biomarker for BLCA, KICH, KIRP, and UCS; while IGF2BP2 is found to be a biomarker for ACC, CESC, LAML, LGG, and PAAD; HNRNPC is a biomarker for LGG; and RBMX is the biomarker for ESCA (Figure 8A). The gene discussed is RBMX; the disease is bladder transitional cell carcinoma.